DnaJ heat shock protein family member A1 pseudogene 6 (DNAJA1P6)

DNAJA1P6 is a pseudogene of the DnaJ (Hsp40) heat shock protein family member A1 (DNAJA1)[2]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional, often due to the accumulation of disabling mutations or lack of regulatory elements[6]. There is no evidence that DNAJA1P6 encodes a functional protein or is involved in disease processes or drug interactions. The parent gene, DNAJA1, is a co-chaperone involved in protein folding and cellular stress responses[1], but these functions do not apply to its pseudogene DNAJA1P6. Key points: - DNAJA1P6 does not encode a protein, nor is it known to act as a therapeutic or molecular target. - There are no common disease associations, biomarkers, or drugs targeting this pseudogene. - DNAJA1P6 exists due to gene duplication or retrotransposition events in the DNAJA1 gene family[2]. - Pseudogenes can sometimes regulate their parent gene via mechanisms such as RNA interference or miRNA decoy activity[6], but there is no specific evidence for such a function for DNAJA1P6. Regarding "is_incorrect": This entry is not a genuine drug target, nor a functional protein or receptor. Its inclusion as a molecular target for therapeutic or drug discovery purposes is incorrect[2][6]. The gene symbol and name are valid as a pseudogene annotation, but there is no biological evidence that it serves as an actual target in the sense used in pharmacology or therapeutic development. Summary: DNAJA1P6 is a non-coding pseudogene with no known biological activity, therapeutic relevance, or clinical significance[2].